Clinical Trial Update: HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating HTD1801 in adults with nonalcoholic steatohepatitis and liver fibrosis who have type 2 diabetes or pre-diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• HTD1801

Snippet

Sponsor: HighTide Biopharma Pty Ltd | Conditions: Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes | Phase 2 | Status: COMPLETED